Search research articles
Contact Us
Filters
Showing results (421-430 of 494) with videos related to
Page
of 50
Sort By:
Molecular Genetics and Metabolism
|
May 19, 2007
A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease
Kerry Anne McEachern, John Fung, Svetlana Komarnitsky, et al.
Nucleic Acids Research
|
April 13, 2024
Quantifying the activity profile of ASO and siRNA conjugates in glioblastoma xenograft tumors in vivo
Samantha L Sarli, Hassan H Fakih, Karen Kelly, et al.
Journal of Medicinal Chemistry
|
May 3, 2017
Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally Bioavailable BET Bromodomain Inhibitor
Yujun Zhao, Longchuan Bai, Liu Liu, et al.
Journal of Medicinal Chemistry
|
June 28, 2019
Structure-Based Discovery of M-89 as a Highly Potent Inhibitor of the Menin-Mixed Lineage Leukemia (Menin-MLL) Protein-Protein Interaction
Angelo Aguilar, Ke Zheng, Tianfeng Xu, et al.
Journal of Medicinal Chemistry
|
March 26, 2024
Discovery of CBPD-409 as a Highly Potent, Selective, and Orally Efficacious CBP/p300 PROTAC Degrader for the Treatment of Advanced Prostate Cancer
Zhixiang Chen, Mi Wang, Dimin Wu, et al.
Biological Psychiatry
|
January 2, 2020
Deletion of Glycogen Synthase Kinase-3β in D<sub>2</sub> Receptor-Positive Neurons Ameliorates Cognitive Impairment via NMDA Receptor-Dependent Synaptic Plasticity
Yan-Chun Li, Priyalakshmi Panikker, Bo Xing, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique
|
December 6, 2024
Building a community of practice to address alcohol harms in Canada: Experience from the Canadian Alcohol Policy Evaluation project
Tina R Price, Bryany Denning, Victoria Burns, et al.
Journal of Medicinal Chemistry
|
March 13, 2024
Discovery of CBPD-268 as an Exceptionally Potent and Orally Efficacious CBP/p300 PROTAC Degrader Capable of Achieving Tumor Regression
Zhixiang Chen, Mi Wang, Dimin Wu, et al.
Plos Pathogens
|
November 6, 2009
A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection
Katharine N Bossart, Zhongyu Zhu, Deborah Middleton, et al.
Journal of Medicinal Chemistry
|
September 23, 2024
Discovery of AK-1690: A Potent and Highly Selective STAT6 PROTAC Degrader
Atsunori Kaneshige, Yiqing Yang, Longchuan Bai, et al.
Page
of 50
Search research articles
Search
Showing results (421-430 of 494) with videos related to
Sort By:
Page
of 50
Molecular Genetics and Metabolism
|
May 19, 2007
A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease
Kerry Anne McEachern, John Fung, Svetlana Komarnitsky, et al.
Nucleic Acids Research
|
April 13, 2024
Quantifying the activity profile of ASO and siRNA conjugates in glioblastoma xenograft tumors in vivo
Samantha L Sarli, Hassan H Fakih, Karen Kelly, et al.
Journal of Medicinal Chemistry
|
May 3, 2017
Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally Bioavailable BET Bromodomain Inhibitor
Yujun Zhao, Longchuan Bai, Liu Liu, et al.
Journal of Medicinal Chemistry
|
June 28, 2019
Structure-Based Discovery of M-89 as a Highly Potent Inhibitor of the Menin-Mixed Lineage Leukemia (Menin-MLL) Protein-Protein Interaction
Angelo Aguilar, Ke Zheng, Tianfeng Xu, et al.
Journal of Medicinal Chemistry
|
March 26, 2024
Discovery of CBPD-409 as a Highly Potent, Selective, and Orally Efficacious CBP/p300 PROTAC Degrader for the Treatment of Advanced Prostate Cancer
Zhixiang Chen, Mi Wang, Dimin Wu, et al.
Biological Psychiatry
|
January 2, 2020
Deletion of Glycogen Synthase Kinase-3β in D<sub>2</sub> Receptor-Positive Neurons Ameliorates Cognitive Impairment via NMDA Receptor-Dependent Synaptic Plasticity
Yan-Chun Li, Priyalakshmi Panikker, Bo Xing, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique
|
December 6, 2024
Building a community of practice to address alcohol harms in Canada: Experience from the Canadian Alcohol Policy Evaluation project
Tina R Price, Bryany Denning, Victoria Burns, et al.
Journal of Medicinal Chemistry
|
March 13, 2024
Discovery of CBPD-268 as an Exceptionally Potent and Orally Efficacious CBP/p300 PROTAC Degrader Capable of Achieving Tumor Regression
Zhixiang Chen, Mi Wang, Dimin Wu, et al.
Plos Pathogens
|
November 6, 2009
A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection
Katharine N Bossart, Zhongyu Zhu, Deborah Middleton, et al.
Journal of Medicinal Chemistry
|
September 23, 2024
Discovery of AK-1690: A Potent and Highly Selective STAT6 PROTAC Degrader
Atsunori Kaneshige, Yiqing Yang, Longchuan Bai, et al.
Page
of 50